GC‐MS separation and quantitation of 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropionic acid and hippuric acid from plasma of patients with renal failure: Application to blood purification methods
- 1 September 1992
- journal article
- research article
- Published by Wiley in Journal of High Resolution Chromatography
- Vol. 15 (9) , 601-604
- https://doi.org/10.1002/jhrc.1240150908
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albuminBiochemical Pharmacology, 1990
- Hippuric acid and 3-car☐y-4-methyl-5-propyl-2-furanpropionic acid in serum and urineJournal of Chromatography A, 1990
- Efficient Removal of Albumin-Bound Furancarboxylic Acid, an Inhibitor of Erythropoiesis, by Continuous Ambulatory Peritoneal DialysisNephron, 1990
- Displacement by Anionic Drugs of Endogenous Ligands Bound to Albumin in Uremic SerumTherapeutic Drug Monitoring, 1988
- Accumulation of furancarboxylic acids in uremic serum as inhibitors of drug bindingClinica Chimica Acta; International Journal of Clinical Chemistry, 1988
- Inhibition of Hepatic Glutathione S-Transferases by a Major Endogenous Ligand Substance Present in Uremic SerumNephron, 1988
- Gas chromatographic determination of hippuric acid and a furancarboxylic acid in plasma of patients with kidney diseasesJournal of Chromatography A, 1987
- Isolation and chemical identification of inhibitors of plasma ligand bindingKidney International, 1986
- Identifizierung, Strukturableitung und Synthese bisher unbekannter Urofuransäuren im menschlichen BlutEuropean Journal of Organic Chemistry, 1981
- Binding of Hippurate in Normal Plasma and in Uremic Plasma Pre- and PostdialysisNephron, 1978